z-logo
open-access-imgOpen Access
HEPATOBLASTOMA: 5-YEAR RETROSPECTIVE STUDY. PEDIATRIC ONCOLOGICAL SURGERY SERVICE “GENERAL ONCOLOGY HOSPITAL.SOLÓN ESPINOSA AYALA” SOLCA QUITO- ECUADOR
Author(s) -
Alexánder Antonio Jara Chávez,
Carolina Vanessa Saldaña Rodríguez,
Silvana Jeannett Suarez Merchan,
Juan Reyes Villacreses,
Víctor Alfonso Terán Pérez,
Yolanda Guzmán Jordán,
Betty Fernandez Santamaria,
Carlos Humberto Vicuña Mariño
Publication year - 2019
Publication title -
global journal for research analysis
Language(s) - English
DOI - 10.36106/gjra/5607168
Subject(s) - hepatoblastoma , medicine , pediatric oncology , retrospective cohort study , pediatric surgery , liver tumor , metastasis , general surgery , surgery , cancer , hepatocellular carcinoma
Objectives: Describe the demographic variables, types of liver tumor, surgeries performed and survivalchildren diagnosed with liver tumor undergoing surgical treatment.Method: A retrospective analysis wasperformed in patients with pediatric liver tumors undergoing surgical treatment, from January 2010 to December 2015 at the"General Oncology Hospital. Solon Espinoza Ayala”.Results: Data from our study reported a diagnosis of hepatoblastoma in 51.85% of all pediatric liver tumors; 50% are routinecontrols without evidence of disease, 14.28% have been completed clinical treatment, 21.42% died from a second primarydiagnosis with metastasis, and another 14.28% (only surgery) who were not followed up because they were transfers fromanother health system; with respect to global survival it was 64%. The ages ranged from 0 to 15 years old with an average of 5.5.Conclusion: It is very important a timely detection and adequate treatment by a specialized center and trained professionals,liver surgery is a very important chapter for the treatment of liver tumors. The surgical approach with tumor-free resection alongwith multidisciplinary treatment is the goal for healing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here